MedPath

Effect of intranasal insulin administering on patients with loss of smell

Not Applicable
Conditions
Hyposmia.
Disturbances of smell and taste
Registration Number
IRCT2017061712782N15
Lead Sponsor
Vice chancellor for research,Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
36
Inclusion Criteria

hyposmic patients with CCCRC scores 2 to 5.75; patients not are under general anesthesia in this treatment; don't use corticosteroid in treatment duration; patients aren't hypoglycemia or diabetes; patients' willingness to participate in the study.
exclusion criteria: patients that cant't follow up in four months after treatment and haven't willingness to continue the study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Intensity of smell. Timepoint: before intervention and four months after intervention. Method of measurement: Connecticut Chemosensory Clinical Research Center test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath